Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. 1995

J Frystyk, and B Dinesen, and H Orskov
Medical Research Laboratories, Aarhus University Hospital, Denmark.

We present sensitive non-competitive time-resolved immunofluorometric assays (TR-IFMAs) for IGF-I and IGF-II based on monoclonal antibodies. Assays were performed in microtest-plate wells: the first antibodies were immobilized on the solid matrix, the second labelled with the chelate derivative of Europium (Eu3+). The obtained specificities and sensitivities were high: IGF-I and IGF-II cross-reactivity in heterologous assay was below 0.0002%. The detection limits were 0.0025 micrograms/l and 0.010 micrograms/l for the IGF-I and IGF-II assay, respectively. The operating range included upwards: 2.5 micrograms/l (IGF-I) and 10.0 micrograms/l (IGF-II). This implies that all clinically relevant serum concentrations could be measured in one final dilution (1:1066 for IGF-I and 1:2132 for IGF-II) after acid ethanol extraction. The high sample dilution with buffer made further neutralization or evaporation of serum acid ethanol extracts unnecessary. Interassay variation of the assays was below 10%.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Frystyk, and B Dinesen, and H Orskov
September 1986, Analytical biochemistry,
J Frystyk, and B Dinesen, and H Orskov
January 1987, Methods in enzymology,
J Frystyk, and B Dinesen, and H Orskov
August 1993, Clinical chemistry,
J Frystyk, and B Dinesen, and H Orskov
April 1986, Clinical chemistry,
J Frystyk, and B Dinesen, and H Orskov
January 2009, Hormone research,
J Frystyk, and B Dinesen, and H Orskov
October 1994, Scandinavian journal of clinical and laboratory investigation,
J Frystyk, and B Dinesen, and H Orskov
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
J Frystyk, and B Dinesen, and H Orskov
April 1996, Clinical biochemistry,
J Frystyk, and B Dinesen, and H Orskov
October 1994, Clinica chimica acta; international journal of clinical chemistry,
J Frystyk, and B Dinesen, and H Orskov
March 2015, Endocrinology and metabolism clinics of North America,
Copied contents to your clipboard!